Young man and health provider sitting on bench

Access for all matters

We're giving every child a fighting chance against T1 Diabetes

Learn more about managing Type 1 diabetes

Primary and secondary osteoporosis and bone health at Stanford Medicine Children's Health

Strong bones

Our team of experts helps pediatric patients live healthy lives

Learn more about bone health

Expert care for the Bay Area

Our multidisciplinary team diagnoses and manages children with endocrine and metabolic disorders

Meet our team

Endocrinology & Diabetes

The endocrine system is a complex collection of hormone-producing glands that control basic body functions such as metabolism, growth and sexual development. The pediatric endocrinology team at Stanford Medicine Children’s Health is top ranked in Northern California in Diabetes & Endocrinology by U.S. News & World Report and treats children with endocrine disorders at convenient locations throughout the Bay Area.

Diagnosis and management of endocrine and metabolic disorders

We diagnose and manage children with many different endocrine and metabolic disorders, including:

Type 1 and Type 2 Diabetes
Adrenal gland disorders
Bone health
Delayed puberty
Disorders of Sexual Differentiation (DSD)
Early puberty
Growth disorders
Hyperthyroidism (Graves' Disease)
Hypothyroidism
Osteoporosis (primary and secondary)
Pituitary gland disorders
Prader-Willi syndrome
Thyroid abnormalities
Turner Syndrome

Research updates

A March 2022 study found bioengineered cone snail venom-human hybrid molecules may provide faster-acting, blood sugar level reducing insulin. Testing in animal models and clinical trials in people are still needed, however, the discovery of this hybrid-insulin could mean patients with diabetes would no longer need to track what they eat or plan insulin doses prior to meals. Learn more >

A November 2021 study found that setting children and teens up with the latest treatment devices shortly after a Type 1 Diabetes diagnosis benefits their health a year later. Children and teens who learned to use continuous glucose monitors (CGMs) within one month of their diabetes diagnosis had healthier blood sugar levels than patients who weren’t given the monitors near the time of diagnosis. Learn more >

An August 2021 review of diabetes telehealth visits occurring before COVID-19, during shelter-in-place orders, and during the reopening period indicates pandemic-related telehealth expansion increased participation of patients with public insurance and those who did not speak English. The finding suggests that prioritizing inclusive telehealth workflows can reduce disparities in access to care for diabetes patients.

A July 2021 study led by Stanford Children’s Health endocrinologists in collaboration with colleagues from the University of Florida, found patients with type 1 diabetes in vulnerable communities often face significant disparities in care. As part of project ECHO Diabetes, adult patients from rural Northern California and Florida were interviewed about challenges they encountered in trying to manage their disease. Learn more >

For clinical questions, please contact the LPCH Diabetes Educators at (650) 498-7353 or diabetes@stanfordchildrens.org.

For research questions, please contact the Stanford Diabetes Research Team at diabetesresearch@stanford.edu.

Please visit dped.stanford.edu for more information about clinical research.